Literature DB >> 10579988

American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma.

.   

Abstract

This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Epidemiology, Diagnosis, and Treatment of Pancreatic Ductal Adenocarcinoma. It was approved by the Clinical Practice and Practice Economics Committee in March 1999 and by the AGA Governing Board in May 1999.

Entities:  

Mesh：

Year:  1999        PMID： 10579988     DOI： 10.1016/s0016-5085(99)70297-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


  30 in total

Review 1.  Pancreatic surgery: evolution and current tailored approach.

Authors:  Mario Zovak; Dubravka Mužina Mišić; Goran Glavčić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.

Authors:  X Yao; M Zeng; H Wang; S Fei; S Rao; Y Ji
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

Review 3.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

4.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

Review 5.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

Review 6.  Biomarkers in gastrointestinal cancers.

Authors:  Rami Badreddine; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2008-07-12       Impact factor: 10.864

7.  Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.

Authors:  Christine Maheu; Andrea Vodermaier; Heidi Rothenmund; Steve Gallinger; Paola Ardiles; Kara Semotiuk; Spring Holter; Saumea Thayalan; Mary Jane Esplen
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 8.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 9.  Pancreatic cancer screening.

Authors:  Eun Ji Shin; Marcia Irene Canto
Journal:  Gastroenterol Clin North Am       Date:  2012-01-05       Impact factor: 3.806

10.  The value of imaging techniques in the staging of pancreatic cancer.

Authors:  J Kulig; T Popiela; A Zajac; S Kłek; P Kołodziejczyk
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.